Why the study?
CMR is useful for establishing the underlying aetiology of MINOCA during the acute phase, but its role in follow-up is less well established.
Does follow-up CMR reveal additional pathology in patients with MINOCA/Takotsubo syndrome?
Does follow-up CMR reveal additional pathology in patients with MINOCA/Takotsubo syndrome?
Follow-up CMR in patients with MINOCA/Takotsubo syndrome may reveal additional actionable pathology such as ischemic injury not apparent during the acute phase.
Answers are grounded in this paper and cite their sources.
Follow-up CMR may detect occult infarction in presumed TTS/MINOCA prompting therapy change; leaves open routine serial imaging value.
Myocardial infarction with non-obstructive coronary arteries is a working diagnosis that includes takotsubo cardiomyopathy/syndrome (TTS). Cardiac magnetic resonance (CMR) is useful for establishing the underlying aetiology of myocardial infarction with non-obstructive coronary arteries during the acute phase, but its role in follow-up is less well established. A 35-year-old man with several cardiac risk factors presented 3 days after his sister's death with biochemical and clinical features of acute myocardial infarction without coronary artery obstruction on angiography but with diagnostic features of TTS on CMR, including oedema but no late gadolinium enhancement. Subsequent CMR 3 months later revealed left ventricular late gadolinium enhancement suggesting previous acute myocardial infarction. Although the initial diagnosis of TTS was robust according to established criteria, it remained uncertain whether the later ischaemic injury was related to an ischaemic event at presentation or occurred in the intervening period. Nevertheless, CMR may have an extended role in the follow-up of these patients and may reveal additional, actionable pathology.
No takes yet. Share an insight, caveat, or question.
Pradhan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: